Labshake search
Citations for R&D Systems :
851 - 900 of 10000+ citations for 7 Chloro 3 methyl 3H 1 2 3 triazolo 4 5 d pyrimidine since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2019Quote: 2 μg of CCL7 in 200 μl PBS (R&D Systems) was injected subcutaneously into mice at 6 weeks of age ...
-
bioRxiv - Cell Biology 2019Quote: ... VEGFR-2 and recombinant human Heparanase were from R&D Systems Inc ...
-
bioRxiv - Immunology 2020Quote: ... and recombinant human Ace-2 (R&D Systems #933-ZN-010) were diluted in OptiMEM to the desired concentrations ...
-
bioRxiv - Cell Biology 2021Quote: ... 2) TGFβ2 (2.5 ng/ml; R&D Systems, Minneapolis, MN, USA), 3 ...
-
bioRxiv - Cell Biology 2020Quote: ... and 2 μg/mL fibronectin (1918-FN, R&D System, USA) in PBS buffer was incubated on a glass-bottom petri dish (D35-14-1.5-N ...
-
bioRxiv - Immunology 2021Quote: ... and 30 IU/ml recombinant human IL-2 (R&D Systems). Prior to transduction with VSVGwt viruses ...
-
bioRxiv - Neuroscience 2021Quote: ... and 2 ng/ml GDNF (R&D Systems 212-GD-050) for a pre-differentiation phase of two days ...
-
bioRxiv - Bioengineering 2023Quote: Recombinant SARS-CoV-2 proteins were purchased from R&D systems. For vaccination ...
-
bioRxiv - Immunology 2023Quote: ... Mouse Lipocalin-2/NGAL DuoSet ELISA kit by R&D Systems was used following the manufacturer’s protocol.
-
bioRxiv - Immunology 2023Quote: ... 10 U/mL human rIL-2 (202-IL, R&D Systems) was added to expand the T cells ...
-
bioRxiv - Bioengineering 2023Quote: ... BMP-2 Quantikine ELISA Kit (biotechne®, R&D systems, UK); alcian blue 8X ...
-
bioRxiv - Cell Biology 2023Quote: ... and 20 ng/ml FGF-2 (R&D Systems, Minneapolis, MN). Media were changed daily ...
-
bioRxiv - Cancer Biology 2023Quote: ... homogenized and digested in Cell Lysis Buffer #2 (R&D Systems) containing protease inhibitors on ice for 1 hour ...
-
bioRxiv - Immunology 2024Quote: Recombinant human IL-2 (Proleukin) was purchased from R&D Systems or obtained from the National Cancer Institute’s Biological Research Branch ...
-
bioRxiv - Neuroscience 2023Quote: ... Ara-C and 2% low-hemoglobin FBS (R&D systems #S11510). iGLUT neurons were distributed among wells (500-750k cells per 24wp or 0.75-1.5E6 cell per 12wp ...
-
bioRxiv - Developmental Biology 2024Quote: For the goat anti-Brachyury antibody (R&D Systems, Table 2), the following protocol was employed ...
-
bioRxiv - Immunology 2024Quote: ... and 100 U/ml IL-2 (R&D Systems, Minneapolis, MN). NK-92 cells were passaged in 2–3 day interval to maintain the cell density at 2.5 × 105 – 1 × 106 cells/ml ...
-
bioRxiv - Bioengineering 2024Quote: ... recombinant human fibroblastic growth factor basic (FGF-2, R&D Systems), dimethyl sulfoxide (anhydrous ...
-
bioRxiv - Bioengineering 2024Quote: ... BMP-2 Quantikine ELISA Kit (biotechne®, R&D systems, UK); Alcian blue 8X ...
-
bioRxiv - Neuroscience 2019Quote: ... Human IFNγ and IL10 were quantified in culture supernatants (1:2 dilution) using DuoSet ELISA kits (R&D Systems). DuoSet ELISA Ancillary Reagent Kit 2 was used in conjunction with all DuoSet ELISA kits ...
-
bioRxiv - Cell Biology 2020Quote: ... Autophagy was induced by treating the cells for 2 hours in 250nM Torin-1 (R&D Systems, 4247/10) in 1X Hanks’ Balanced salt solution ...
-
bioRxiv - Cancer Biology 2023Quote: ... in 2% BSA/PBS solution and the appropriate fluorescently-conjugated secondary antibody (R&D Systems catalog #NL006, 1:200). Coverslips were mounted onto slide with DAPI-containing ProLong Gold media ...
-
bioRxiv - Cancer Biology 2021Quote: ... 5 ng/mL IL-12 (R&D Systems, cat#219-IL-005), 10 ng/mL IL-15 (NCI preclinical repository) ...
-
bioRxiv - Genomics 2019Quote: ... after treatment with human recombinant IFNg (5 ng/mL, R&D Systems) overnight and stimulation with PMA (30 ng/mL ...
-
bioRxiv - Bioengineering 2019Quote: ... FN hydrogels (5 wt.%, 0.5VPM) were loaded with BMP2 (R&D Systems) at a final concentration of 0 ...
-
bioRxiv - Immunology 2022Quote: ... or NKG2D neutralizing antibody (5 µg/ml, R&D Systems, MAB139-100); ILC1-like cells demonstrated cytotoxic effect on HFs with 600 cells per well ...
-
bioRxiv - Immunology 2022Quote: ... or function-blocking NKG2D (5 µg/ml, R&D Systems, MAB139-100) antibodies ...
-
bioRxiv - Developmental Biology 2023Quote: ... 5 ng/ml BMP7 (R&D Systems, cat# 354-BP-500/CF), and 50 ng/ml BMP12/GDF7 (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... plus 5 ng/mL of recombinant mouse IL-18 (R&D Systems). To retain intracellular mediators for downstream cytofluorimetric analyses ...
-
bioRxiv - Immunology 2023Quote: BMDMs were primed with murine IFNγ (5 ng/ml, R&D systems) for 16 h ...
-
bioRxiv - Molecular Biology 2023Quote: ... and 5 ng/ml human VEGF (R&D Systems Cat#. 293-VE). The 2-day-old EBs were dissociated and 6 × 104 cells were seeded onto individual wells of a 24-well plate coated with 0.1% gelatine in EC Induction Medium consisting of StemPro-34 medium (Gibco #10639011) ...
-
bioRxiv - Molecular Biology 2023Quote: ... After addition of 5 µl ISG15-AMC (R&D Systems #UL-553) substrate ...
-
bioRxiv - Developmental Biology 2024Quote: ... BPEL containing WNT inhibitor XAV939 (5 μmol/L, R&D Systems 3748) was used to refresh cells ...
-
Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutationsbioRxiv - Genomics 2024Quote: ... or 5 µg of AREG neutralizing antibody (R&D Systems, MAB262-SP) or an equivalent volume of PBS ...
-
bioRxiv - Immunology 2024Quote: ... primary dFBs were treated with IFNγ (5 ng/ml, R&D Systems) or PBS control for 2 hours ...
-
bioRxiv - Neuroscience 2024Quote: ... myogenic factor 5 (MYF5) (mouse monoclonal, MAB4027, R&D Systems, Minneapolis, USA), myosin heavy chain (MYHC ...
-
bioRxiv - Immunology 2024Quote: ... IL-5 and IL-13 were measured by ELISA (R&D systems). Results were normalized to cell number using CyQuant cell proliferation assay (Invitrogen ...
-
bioRxiv - Molecular Biology 2023Quote: ... 5 mM ATP) with 0.1 μM recombinant yeast E1 (R&D Systems), ...
-
bioRxiv - Neuroscience 2023Quote: ... Primary antibodies (DCX, Goat anti-doublecortin, 1:500, Santa Cruz; SOX2, Goat anti-sex determining region Y-box 2, 1:200, R&D Systems; CLR ...
-
bioRxiv - Developmental Biology 2019Quote: ... goat-α-neuorpilin-1 (1:400, R&D Systems), mouse-α-ROBO2(1:50 ...
-
bioRxiv - Neuroscience 2022Quote: ... Nestin (1:2000–1:5000, R&D Systems, MAB1259), Pax6 (1:300 ...
-
bioRxiv - Immunology 2023Quote: ... anti-mLamp-1 (1:1000, AF4320, R&D Systems), anti-Phospho-p38 (1:1000 ...
-
bioRxiv - Genetics 2023Quote: ... Parvalbumin (R&D system AF5058, 1:50 – 1:100), cFOS (Santa Cuz s-166940 ...
-
Prevention of tau accumulation through inhibition of hnRNP R-dependent axonal Mapt mRNA localizationbioRxiv - Neuroscience 2023Quote: ... 1 µM dorsomorphin homolog 1 (4126, R&D Systems), 3 µM CHIR99021 (13122 ...
-
bioRxiv - Immunology 2022Quote: ... and 1 μg/ml CD40-ligand-HA with 5 ng/ml anti-HA antibodies (both R&D Systems, Minneapolis, USA), and Type B CpG OND D-SL01 (InvivoGen ...
-
bioRxiv - Microbiology 2022Quote: ... Blots were incubated for 1 hour with HRP-conjugated secondary antibodies diluted in 5% skim milk: anti-mouse (HAF007, R&D Systems, 1:25,000); anti-rabbit (111-035-144 ...
-
bioRxiv - Pathology 2022Quote: ... blocking-and antibody-incubations were performed in TBS + 0,1% Tween20 + 5% milk. Following primary antibodies (Suppl. Table 1) were used: anti-NRP1 (1:1000, R&D Systems, Cat. No. AF566), anti-NRP2 (1:1000 ...
-
bioRxiv - Immunology 2020Quote: ... For iTreg cell differentiation we additionally added the following cytokines and blocking antibodies: rmIL-2 and rmTGF-β (both: R&D Systems, 5 ng/ml), anti-IL-4 (clone ...
-
bioRxiv - Neuroscience 2021Quote: ... samples were incubated overnight at 4°C with mouse anti-mCRP antibody (1:50, 3H12) and either goat anti-CD31 antibody (1:200, #AF3628, R&D systems, Minneapolis, MN, USA) for mouse samples or rabbit anti-CD31 antibody (1:200 ...
-
bioRxiv - Developmental Biology 2023Quote: ... blocked using 5% donkey serum or 5% BSA in PBST for 1 hour at RT and incubated overnight at 4°C with primary antibodies diluted in the blocking solution: CD31 (R&D systems; AF3628; 1:500), Aggrecan (Millipore ...